Phase I clinical and pharmacokinetic study of combination chemotherapy with topotecan and ifosfamide in patients with progressive or relapsed solid tumors.

被引：0

作者：

C.-P. Schneider

U. Merkel

U. Grübner

R. Kath

K. Höffken

A. Hoffmann

机构：

[1] Department of Internal Medicine II (Hematology,

[2] Oncology,undefined

[3] Endocrinology and Metabolic Diseases),undefined

[4] Friedrich-Schiller University Jena,undefined

[5] Erlanger Allee 101,undefined

[6] 07740 Jena,undefined

[7] Germany ,undefined

[8] Institute for Clinical Pharmacology,undefined

[9] Friedrich-Schiller University Jena,undefined

[10] Jena,undefined

[11] Germany,undefined

来源：

Journal of Cancer Research and Clinical Oncology | 2002年 / 128卷

关键词：

Topotecan Ifosfamide Solid tumor Chemotherapy Refractory cancer;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：313 / 318

页数：5